| Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus L Muller, KJ Gorter, E Hak, WL Goudzwaard, FG Schellevis, ... Clinical infectious diseases 41 (3), 281-288, 2005 | 1257 | 2005 |
| Effectiveness of influenza vaccine in the community-dwelling elderly KL Nichol, JD Nordin, DB Nelson, JP Mullooly, E Hak New England Journal of Medicine 357 (14), 1373-1381, 2007 | 858 | 2007 |
| Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia M Koeman, AJAM Van Der Ven, E Hak, HCA Joore, K Kaasjager, ... American journal of respiratory and critical care medicine 173 (12), 1348-1355, 2006 | 610 | 2006 |
| β-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease FH Rutten, NPA Zuithoff, E Hak, DE Grobbee, AW Hoes Archives of internal medicine 170 (10), 880-887, 2010 | 461 | 2010 |
| Evaluation of impermeable covers for bedding in patients with allergic rhinitis I Terreehorst, E Hak, AJ Oosting, Z Tempels-Pavlica, JGR de Monchy, ... New England Journal of Medicine 349 (3), 237-246, 2003 | 308 | 2003 |
| Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations E Hak, J Nordin, F Wei, J Mullooly, S Poblete, R Strikas, KL Nichol Clinical Infectious Diseases 35 (4), 370-377, 2002 | 290 | 2002 |
| Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection JJ Oosterheert, AM Van Loon, R Schuurman, AIM Hoepelman, E Hak, ... Clinical infectious diseases 41 (10), 1438-1444, 2005 | 256 | 2005 |
| Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study E Hak, E Buskens, GA van Essen, DH de Bakker, DE Grobbee, ... Archives of internal medicine 165 (3), 274-280, 2005 | 247 | 2005 |
| Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program E Hak, Y Schönbeck, H De Melker, GA Van Essen, EAM Sanders Vaccine 23 (24), 3103-3107, 2005 | 237 | 2005 |
| Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults E Hak, DE Grobbee, EA Sanders, TJ Verheij, M Bolkenbaas, SM Huijts, ... Neth J Med 66 (9), 378-383, 2008 | 232 | 2008 |
| First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission … A Mailles, K Blanckaert, P Chaud, S Van der Werf, B Lina, V Caro, ... Eurosurveillance 18 (24), 2013 | 218 | 2013 |
| Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis IS Pradipta, LD Forsman, J Bruchfeld, E Hak, JW Alffenaar Journal of Infection 77 (6), 469-478, 2018 | 215 | 2018 |
| Influenza-and respiratory syncytial virus-associated mortality and hospitalisations AGSC Jansen, EAM Sanders, AW Hoes, AM van Loon, E Hak European Respiratory Journal 30 (6), 1158-1166, 2007 | 197 | 2007 |
| Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome AGSC Jansen, GD Rodenburg, A van der Ende, L van Alphen, ... Clinical infectious diseases 49 (2), e23-e29, 2009 | 191 | 2009 |
| Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands GD Rodenburg, SC de Greeff, AGCS Jansen, HE de Melker, LM Schouls, ... Emerging infectious diseases 16 (5), 816, 2010 | 189 | 2010 |
| Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial EJM van Gils, RH Veenhoven, E Hak, GD Rodenburg, D Bogaert, ... Jama 302 (2), 159-167, 2009 | 187 | 2009 |
| Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia AHW Bruns, JJ Oosterheert, E Hak, AIM Hoepelman European Respiratory Journal 32 (3), 726-732, 2008 | 180 | 2008 |
| Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications E Hak, TJM Verheij, DE Grobbee, KL Nichol, AW Hoes Journal of Epidemiology & Community Health 56 (12), 951-955, 2002 | 169 | 2002 |
| Statin treatment and reduced risk of pneumonia in patients with diabetes EMW van de Garde, E Hak, PC Souverein, AW Hoes, JMM van den Bosch, ... Thorax 61 (11), 957-961, 2006 | 166 | 2006 |
| Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients I Looijmans-Van den Akker, TJM Verheij, E Buskens, KL Nichol, ... Diabetes care 29 (8), 1771-1776, 2006 | 166 | 2006 |
Maarten PostmaProfessor in PharmacoEonomics在 rug.nl 的电子邮件经过验证
